Novel human CYP2A6 alleles confound gene deletion analysis

FEBS Letters
Miki NakajimaT Yokoi

Abstract

Cytochrome P450 (CYP) 2A6 metabolizes a number of drugs and a variety of procarcinogens. CYP2A6 also catalyzes nicotine C-oxidation leading to cotinine formation, a major metabolic pathway of nicotine in humans. There are genetic polymorphisms in the human CYP2A6 gene and a relationship between the CYP2A6 genotype and smoking habits as well as the incidence of lung cancer has been indicated. CYP2A6*4 alleles are the whole deleted type and are completely deficient in the enzymatic activity. An unequal crossover junction is located in the 3'-flanking region in the CYP2A6*4A allele, whereas the junction is located in either intron 8 or exon 9 in the CYP2A6*4D allele. In the present study, a novel genotyping method to distinguish between two different whole deleted alleles of CYP2A6*4A and CYP2A6*4D was established. In the process, two novel alleles, CYP2A6*1F and CYP2A6*1G, were found. The CYP2A6*1F has a single nucleotide polymorphism (SNP) of C5717T in exon 8, and the CYP2A6*1G has two SNPs, C5717T in exon 8 and A5825G in intron 8. The SNP of C5717T corresponds to C1224T on the cDNA sequence and is a synonymous mutation. Since the CYP2A6*1F produces a recognition site of the restriction enzymes that is the same as CYP2A6*4D, the...Continue Reading

References

Jul 9, 1998·Nature·M L PianezzaR F Tyndale
Aug 12, 1999·Biochemical and Biophysical Research Communications·M MiyamotoT Kamataki
Mar 10, 2001·Biochemical and Biophysical Research Communications·N AriyoshiT Kamataki
Jun 8, 2001·Biochemical and Biophysical Research Communications·M PitarqueM Ingelman-Sundberg
Jul 4, 2001·Pharmacogenetics·J T KwonT Yokoi
Dec 26, 2001·Clinical Pharmacology and Therapeutics·N L BenowitzR Tyndale
Jan 10, 2002·Biochemical and Biophysical Research Communications·C XuR F Tyndale
Sep 27, 2002·Human Mutation·Mikael OscarsonMagnus Ingelman-Sundberg
Nov 26, 2002·British Journal of Clinical Pharmacology·Ryoko YoshidaTsuyoshi Yokoi
Dec 19, 2002·Drug Metabolism Reviews·Miki NakajimaTsuyoshi Yokoi
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Kazuma KiyotaniTetsuya Kamataki

❮ Previous
Next ❯

Citations

Jan 22, 2005·European Journal of Clinical Pharmacology·Maxwell Afari GyamfiTetsuya Kamataki
Nov 4, 2008·European Journal of Clinical Pharmacology·M I VeigaJ P Gil
Nov 19, 2009·Cancer Chemotherapy and Pharmacology·Yukimoto IshiiSatoshi Asai
Apr 26, 2006·The Pharmacogenomics Journal·T FukamiT Yokoi
Jul 26, 2005·Pharmacogenetics and Genomics·Michael HaberlLeszek Wojnowski
Nov 6, 2007·Pharmacogenomics·Jill C Mwenifumbo, Rachel F Tyndale
Feb 19, 2014·Pharmacogenomics·Marco Alessandrini, Michael S Pepper
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Apr 18, 2013·Drug Metabolism Reviews·Marco AlessandriniMichael Sean Pepper
Sep 16, 2015·Fukushima Journal of Medical Science·Teruna ItoAnd Tetsuhito Fukushima
Apr 14, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wardah Yusof, Siew Hua Gan
Feb 24, 2006·Journal of Clinical Pharmacology·Miki NakajimaTsuyoshi Yokoi
Sep 30, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Yevgeniya SvyrydOsvaldo M Mutchinick
Sep 16, 2011·Journal of Clinical Laboratory Analysis·Toshihiro InoItsuro Yoshimi
Jan 27, 2011·Fundamental & Clinical Pharmacology·D KrishnakumarC Adithan
Jul 22, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hiroyuki YamanakaTsuyoshi Yokoi
Mar 6, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Peter GresnerWojciech Wasowicz
Sep 1, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Amit SharmaDevendra Parmar
Nov 10, 2004·The Pharmacogenomics Journal·G M VasconcelosG Suarez-Kurtz
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Angela Risch, Christoph Plass
Jul 9, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ikuo YamamiyaMasato Chiba
Sep 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miki KatohTsuyoshi Yokoi
Feb 3, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatsuki FukamiTsuyoshi Yokoi
May 19, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatsuki FukamiTsuyoshi Yokoi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.